- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02190955
Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome
Assessment of the Educational Experience for Patients With Newly Diagnosed Nephrotic Syndrome
Study Overview
Status
Conditions
Detailed Description
The survey included questions addressing the following areas: 1.) Information that is important to know when learning to manage Nephrotic Syndrome. 2.) Preferred resources for the education of patients and caregivers with newly-diagnosed Nephrotic Syndrome. 3.) The time frame required to acquire confidence in the management of Nephrotic Syndrome. 4.) Disease-specific information such as diagnosis, length of disease duration, medications used, need for kidney biopsy, dialysis and/or transplant. 5.) Demographic data such as race/ethnicity and educational background.
The survey data is stored by the Rare Diseases Clinical Research Network's Data Management and Coordinating Center (DMCC) at the University of South Florida. The data is de-identified. Names or other personal health information were not collected. Upon conclusion of the study period, the data will be sent to the NEPTUNE consortium lead at the University of Michigan.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- University of South Florida Data Management and Coordinating Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients and caregivers were recruited from the Nephrotic Syndrome Study Network (NEPTUNE) Patient Contact Registry. Over 1000 patients and caregivers are members of the registry and have already provided permission to be contacted for future research studies. The Contact Registry was created to inform patients and/or parents of patients with Nephrotic Syndrome of clinical research studies.
Health professionals, including pediatric and internal medicine nephrologists and nephrology nurses will be recruited from the 18 NEPTUNE study network sites.
Description
Inclusion Criteria:
Patient and Patient Caregiver:
- 18 years or older
- English literate
- History of Nephrotic Syndrome > 3 months or caregiver of a child diagnosed with Nephrotic Syndrome > 3 months prior to enrollment
- Informed Consent
Healthcare Worker Inclusion Criteria:
- Age > 18 years
- English literate
- Provides medical care for children or adults with Nephrotic Syndrome
- Informed Consent
Exclusion Criteria:
- Inability to provide informed consent and complete survey
- Other criteria as specified by Consortium and based on the data we collect in the Contact Registry
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
NEPTUNE contact registry patients
Patients and caregivers will be recruited from the Nephrotic Syndrome Study Network (NEPTUNE) Patient Contact Registry.
Over 1000 patients and caregivers are members of the registry and have already provided permission to be contacted for future research studies.
Analysis of the one-time online questionnaire will be done in collaboration with investigators from the NEPTUNE Consortium.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stakeholder perspectives about educational experiences of newly-diagnosed Nephrotic Syndrome patients
Time Frame: 1 year after the study is closed to enrollment
|
The outcome measure(s) will be evaluated based on the cross-sectional online questionnaire.
The questionnaire is the only study procedure for this online patient contact registry protocol and will be the sole analysis tool for both the primary and secondary outcome measures.
|
1 year after the study is closed to enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perspectives of patients/families with healthcare workers regarding educational needs of newly-diagnosed Nephrotic Syndrome
Time Frame: 1 year after the study is closed to enrollment
|
The outcome measure(s) will be evaluated based on the cross-sectional online questionnaire.
The questionnaire is the only study procedure for this online patient contact registry protocol and will be the sole analysis tool for both the primary and secondary outcome measures.
|
1 year after the study is closed to enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Marie Tanzer, MD, Maine Medical Partners
- Study Chair: Debbie Gipson, MD, C.S. Mott Children's Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6802
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nephrotic Syndrome
-
University of CalgaryUnknownNephrotic Syndrome in Children | Nephrotic Syndrome, Minimal Change | Nephrotic Syndrome,IdiopathicCanada
-
Nationwide Children's HospitalGenentech, Inc.; Emory University; Children's Healthcare of Atlanta; The NephCure...TerminatedSteroid Dependent Nephrotic Syndrome | Frequent Relapsing Nephrotic SyndromeUnited States
-
Seoul National University Childrens HospitalUnknownSteroid Resistant Nephrotic Syndrome | Steroid Dependent Nephrotic SyndromeKorea, Republic of
-
Children's Hospital of Fudan UniversityShanghai Children's Hospital; Shanghai Children's Medical Center; Xinhua Hospital...WithdrawnSteroid-Dependent Nephrotic Syndrome | Frequently Relapsing Nephrotic SyndromeChina
-
University Hospital, LimogesHoffmann-La RocheCompletedChildhood Idiopathic Nephrotic SyndromeFrance, Belgium
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Cell Factory Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Laboratorio...CompletedIdiopathic Nephrotic Syndrome | Nephrotic Syndrome in Children | Steroid-Dependent Nephrotic SyndromeItaly
-
Assistance Publique - Hôpitaux de ParisRecruitingMinimal Change Nephrotic Syndrome (MCNS)France
-
Astellas Pharma Korea, Inc.CompletedMinimal Change Nephrotic Syndrome (MCNS) | MCNSKorea, Republic of
-
Northwell HealthCompletedIdiopathic Nephrotic Syndrome | Frequently Relapsing Nephrotic SyndromeUnited States
-
Nanjing University School of MedicineCompletedGlucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational StudyNephrotic Syndrome,IdiopathicChina